195. CYP2C9 genetic polymorphism significantly affected the pharmacokinetics of candesartan and its metabolite.

  • Byeon, Ji-Yeong B.S.
  • Park, Jung-In B.S.
  • Jang, Choon-Gon Ph.D.
  • Lee, Seok-Yong Ph.D.

  • School of Pharmacy, Sungkyunkwan University, Suwon, South Korea

Pharmacotherapy: The Journal Of Human Pharmacology & Drug Therapy 32(10):p e235, October 2012.
Copyright © 2012 John Wiley & Sons, Inc.